What Amgen's Dividend Increase Means for Mutual Fund Investors (AMGN)

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Find the latest content and information here about the 2019 Charles Schwab Impact Conference.


Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

Amgen logo in blue


What Amgen's Dividend Increase Means for Mutual Fund Investors (AMGN)

Shauna O'Brien Dec 18, 2014

Biotech giant Amgen (AMGN) announced after Wednesday’s closing bell that it has boosted its dividend by 30%. Here’s what the news means for mutual fund investors.

Inside AMGN’s Dividend Boost

Amgen has boosted its quarterly dividend from 61 cents to 79 cents, or $3.16 annually. The next dividend will be paid on March 6 to shareholders of record on February 12. The stock will be going ex-dividend on February 10. The new payout is a 30% increase from the stock’s previous dividend.

Healthy Dividend for income-Focused Investors

Biotech has had a great year in 2014, and this run has not excluded Amgen. The stock is a main play in the industry and is up nearly 50% this year. For dividend investors, this most recent boost is a very healthy increase and is ideal for a dividend growth investor. Investors should be aware that a stock like Amgen is much more volatile than larger pharmaceutical names. In 2013, the stock also boosted its dividend by 30%.

Mutual Funds to Watch

Investors seeking exposure to AMGN may consider one the funds below as an alternative to investing directly in the stock. These funds currently have the largest stakes in the company.

The Bottom Line

The funds above offer investors a diversified bundle of securities and industries. Investors interested in AMGN may also be interested in Johnson & Johnson (JNJ) and GlaxoSmithKline (GSK).

Shares of AMGN are up 45% YTD.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Please Enter Your Email
Please Select Your Advisor Type

Popular Articles

Download Our Free Report

Why 30 trillion is invested in mutual funds book